Related Experiment Video

Updated: May 29, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

The role of autophagy in cancer: therapeutic implications

Zhineng J Yang1, Cheng E Chee, Shengbing Huang

  • 1Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

Molecular Cancer Therapeutics
|September 1, 2011
PubMed

Insights

Autophagy, a cellular recycling process, plays a dual role in cancer. Inhibiting autophagy can enhance cancer cell death and improve treatment effectiveness, making it a promising therapeutic target.

Area of Science:

  • Cell Biology
  • Oncology
  • Biochemistry

Background:

  • Autophagy is a fundamental cellular process for degrading damaged components and maintaining homeostasis.
  • In cancer, autophagy exhibits paradoxical roles, acting as a tumor suppressor and promoting tumor cell survival.
  • Cancer cells exploit autophagy to cope with stress and metabolic demands, contributing to therapeutic resistance.

Purpose of the Study:

  • To investigate the role of autophagy in cancer progression and therapeutic resistance.
  • To evaluate the potential of autophagy inhibition as a cancer treatment strategy.
  • To identify the need for more effective autophagy inhibitors in cancer therapy.

Main Methods:

  • Review of preclinical models demonstrating the effects of autophagy inhibition.
  • Analysis of early-phase clinical trials evaluating autophagy inhibitors like hydroxychloroquine.
  • Exploration of the regulatory mechanisms of autophagy in cancer cells.

Main Results:

  • Inhibition of autophagy in preclinical models restored sensitivity to chemotherapy and increased tumor cell death.
  • Autophagy contributes to cancer cell survival, energy production, and resistance to therapies.
  • Clinical trials are exploring the combination of autophagy inhibitors with conventional cancer treatments.

Conclusions:

  • Autophagy is a validated therapeutic target in oncology.
  • Targeting autophagy presents new avenues for drug development in cancer treatment.
  • Further research is needed to optimize strategies for modulating autophagy for maximum therapeutic benefit.

More Related Videos

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...